Are you sure you want to leave this community? Leaving the community will revoke any permissions you have been granted in this community.
Health-related quality of life (HRQL) is an important goal for patients with major depressive disorder (MDD), but whether antidepressants improve HRQL in these patients is unclear. Here, we describe the real-world effects of trazodone once-a-day (TzOAD) and selective serotonin reuptake inhibitor (SSRI) treatments on HRQL and functioning in adults with MDD.
Pubmed ID: 39034363
Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.
Repository of person centered measures that evaluates and monitors physical, mental, and social health in adults and children.
View all literature mentions